$0.4407
-0.02-3.46%
At close: -
$0.4309
-0.00980-2.22%
After Hours: Jan 17, 5:42 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for CARISMA Therapeutics in recent months.
Browse guidance and forecast on all stocks.